Public Policy Studies
Our expertise in economics and finance, combined with our knowledge of the health care industry's many dimensions and diverse participants, uniquely qualify Analysis Group to bring informed insights to public policy issues in health care. Our work not only helps the industry to understand the impact of public policy shifts, it also helps prepare companies for the sweeping changes that continue to shape our dynamic health care environment.
Much of our public policy work is high-profile, ranging from an assessment of the economic impact of implementing the stem cell research initiative in California to an analysis of generic competition in the U.S. pharmaceutical industry.
We have also analyzed how the market for follow-on biologics will evolve, in comparison to the development of the generics market for pharmaceutical drugs.
In each of these and additional studies, we bring academic rigor and objectivity to bear, often working alongside leading scholars and authorities, and focusing on prominent, sometimes controversial issues. The results of our work have informed referenda, Congressional debate, and health care industry forums, and been published in white papers, testimony, and health policy journals.